Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis - Test2 - elhamkhani - TriplyDB

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q24299487

about

Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease Transmission and spreading of tauopathy in transgenic mouse brain XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders The microglial-motoneuron dialogue in ALS Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease Microglia centered pathogenesis in ALS: insights in cell interconnectivity In Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS The Cu, Zn Superoxide Dismutase: Not Only a Dismutase Enzyme The complex molecular biology of amyotrophic lateral sclerosis (ALS)Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic Mechanisms underlying inflammation in neurodegeneration Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons.Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis.Glial cell lineage expression of mutant ataxin-1 and huntingtin induces developmental and late-onset neuronal pathologies in Drosophila models Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis Inflammation in ALS and SMA: sorting out the good from the evil.Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis.Modelling amyotrophic lateral sclerosis: progress and possibilities SOD1, an unexpected novel target for cancer therapy Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS.D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis.Mitochondrial dysfunction and intracellular calcium dysregulation in ALS Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes Cytotoxicity of superoxide dismutase 1 in cultured cells is linked to Zn2+ chelation.Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis.Hyperphosphorylation and cleavage at D421 enhance tau secretion

P2860

72a2b4eae673988c0f3ea419c457a2ea11774223 79ccc09ab5838cb953b8c4788c37eb27131e01e5 ead2680e7b84bb70217432ce57f1f531322ccdf0

P248

Q21136374-9E1A09FB-8F9F-449B-9C43-79F85D12D069 Q24302479-CF44B17A-77EC-4980-A214-9ADB37A0B7CF Q24610255-52F6A39B-573F-4E02-BDAC-DAB399670B38 Q24621854-F87DAC9D-0B74-4EFA-9D2E-D8536829247F Q24651334-9581E4DB-E541-406B-80B1-469B910E17E6 Q24655821-E87F8642-F421-42C5-884F-8B96EFB2DEC8 Q26773168-2B548367-0948-4252-A380-DB72C669EA25 Q26774824-088E9DFC-BDE3-4BE0-B60F-ADE64D20B197 Q26800781-FDD34D0A-3065-43B0-941D-B05CE0AB31CB Q26850298-DDF96485-D619-46E4-BFA5-AD00ADF70154 Q27000470-EF5211C5-B4A3-4528-AAE2-6DC0555ED25F Q27005843-BF340379-922A-4642-8DD5-6C6F8E7BB863 Q27009559-F053AA3B-C527-4B3A-8F38-40246C359270 Q27349669-4D19EA15-B5E9-4F36-A044-2391571ADDEC Q28076049-F75C0BBA-8D21-41A8-A698-9C2E9E5758C2 Q28263899-F2D4C765-5885-4BAF-A6B4-7D2B2C2E424E Q28477629-5BDE9557-4A2C-411D-99FF-399A04A9CA11 Q28483618-E664A137-F5C3-4F80-AEC6-1C1CC9F8ED47 Q29617977-12BEE8BC-B141-425A-920A-7F9A3FFDF55D Q30155471-8A71EB2B-DFAE-4BFF-B567-3A56AE76CEAF Q30497215-280B0899-2F36-474C-A5F9-40A3E15D8E1F Q33282966-3BF38821-0C41-46A5-AA49-BEE3973C7282 Q33303468-198F946F-782C-40A4-9111-9C33C1CCCC26 Q33402470-F85841AB-3B69-42DF-8211-4B27E477599B Q33564738-90EB36DD-C158-4DEC-B952-4A61476FDEDC Q33640597-F0789C1E-43C5-453C-88CD-064C8B19CE36 Q33664711-7E59A7B0-DB75-49DB-AEBA-847D7CEFA98B Q33703773-315628D6-ABA3-4121-B013-7E4C780E0995 Q33746289-F90A450B-CB60-4F28-BC91-D87B2B275210 Q33776847-72729ECC-A568-4732-9BFC-89CF4C279888 Q33874305-433808A4-DF1B-4330-858C-30C0CEE93346 Q33979028-7299CCA1-341D-458F-9958-610C0709E4B1 Q34006224-122E7048-F68E-4C5F-8E7E-DBAE5B421687 Q34059225-7C7C31CB-5322-4D04-99EF-C867C71146E3 Q34103782-85FB1982-45A8-48DF-997D-A85E30AB793C Q34139970-6DC3B2DE-A999-4701-ADBE-9717798020E8 Q34187119-D38A78C8-47C9-441A-81B6-B8593F876214 Q34257147-BF06B8C4-2BE4-4D96-AFEF-BE6221D7304C Q34266579-25C3D190-1CCD-464F-89CC-252F64862CEB Q34277477-A51C9D60-13B3-4370-B785-EA233038709D

P2860

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q24299487

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@ast

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@en

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@en-gb

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@nl

type

label

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@ast

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@en

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@en-gb

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@nl

prefLabel

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@ast

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@en

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@en-gb

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@nl

P1433

Q24299487-E7A3B279-3EBB-4453-B5CD-F163B45F21A5

P1476

Q24299487-1E67C953-DE6E-45A0-B31C-A7C9D69FC9DD

P2093

Q24299487-084351C1-8279-4233-9EA5-FB7503C142E4

Q24299487-50C2BB88-84CF-4309-BC1C-A06E2FB5807E

Q24299487-5F3ABC78-CDE2-4284-BBCE-5EA49FEF7728

Q24299487-7B420A60-8271-4E7D-8872-96750F495769

Q24299487-BD33D9D4-4D3C-408C-A7F2-0FF5C169BDBE

P2888

Q24299487-7E9A8411-4F2F-417A-94FE-4BF42E584AA5

P304

Q24299487-7B28F873-3E49-49AC-BA96-19876E092CB8

P31

Q24299487-37F692FC-DCDD-48A6-B71D-71D53AA87658

P3181

Q24299487-911E9848-2104-4410-AE9F-2F57D4463D83

P356

Q24299487-8570D148-7566-44FC-B7C4-97D958EE1D7F

P407

Q24299487-3F161277-BA79-4A50-A27C-8BB16FB29A58

P433

Q24299487-D719167A-1387-40D6-B622-D6F044D79DEF

P478

Q24299487-0B23CC84-5D47-4D1D-AFC0-E1F841EECD56

P50

Q24299487-A03C76A1-A632-406C-A7FE-50372573A56E

P577

Q24299487-87ADEEEB-5432-4199-8DA9-728FDC24E961

P6179

Q24299487-F3642AEC-1899-49F0-82D7-63782CE52475

P698

Q24299487-B3D96DDB-F414-4CAE-BB61-135958D9BC14

P921

Q24299487-6483B1B9-987D-4347-B72D-CF69A1A435AE

Q24299487-80D34445-17F9-4A53-B247-9467A0BEC338

Q24299487-DC1BBF20-6C7F-42B7-AF4F-22FA24D21D7D

P3181

P356

P1433

Nature Neuroscience

P1476

Chromogranin-mediated secretio ...... amyotrophic lateral sclerosis

@en

P2093

Attila Sik

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Julien

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Nukina

http://www.w3.org/2001/XMLSchema#string

Ryosuke Takahashi

http://www.w3.org/2001/XMLSchema#string

Takashi Sakurai

http://www.w3.org/2001/XMLSchema#string

P2888

P304

108-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

903143

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NN1603

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Makoto Urushitani

P577

2005-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051134476

http://www.w3.org/2001/XMLSchema#string

P698

16369483

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis